Abstract:Abstract Synthetic biology approach has been frequently applied to produce plant rare bioactive compounds in microbial cell factories by fermentation. However, to reach an ideal manufactural efficiency, it is necessary to optimize the microbial cell factories systemically by boosting sufficient carbon flux to the precursor synthesis and tuning the expression level and efficiency of key bioparts related to the synthetic pathway. We previously developed a yeast cell factory to produce ginsenoside Rh2 from glucose. However, the ginsenoside Rh2 yield was too low for commercialization due to the low supply of the ginsenoside aglycone protopanaxadiol (PPD) and poor performance of the key UDP-glycosyltransferase (UGT) (biopart UGTPg45) in the final step of the biosynthetic pathway. In the present study, we constructed a PPD-producing chassis via modular engineering of the mevalonic acid pathway and optimization of P450 expression levels. The new yeast chassis could produce 529.0 mg/L of PPD in shake flasks and 11.02 g/L in 10 L fed-batch fermentation. Based on this high PPD-producing chassis, we established a series of cell factories to produce ginsenoside Rh2, which we optimized by improving the C3–OH glycosylation efficiency. We increased the copy number of UGTPg45, and engineered its promoter to increase expression levels. In addition, we screened for more efficient and compatible UGT bioparts from other plant species and mutants originating from the direct evolution of UGTPg45. Combining all engineered strategies, we built a yeast cell factory with the greatest ginsenoside Rh2 production reported to date, 179.3 mg/L in shake flasks and 2.25 g/L in 10 L fed-batch fermentation. The results set up a successful example for improving yeast cell factories to produce plant rare natural products, especially the glycosylated ones.

Production of Triterpene Ginsenoside Compound K in the Non-conventional Yeast Yarrowia Lipolytica

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

Iterative gene integration mediated by 26S rDNA and non-homologous end joining for the efficient production of lycopene in Yarrowia lipolytica

Cell-Free Production of Pentacyclic Triterpenoid Compound Betulinic Acid from Betulin by the Engineered Saccharomyces cerevisiae.

Boosting the biosynthesis of betulinic acid and related triterpenoids in Yarrowia lipolytica via multimodular metabolic engineering

Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides

Cultivation optimization promotes ginsenoside and universal triterpenoid production by engineered yeast

Production of ginsenoside compound K by microbial cell factory using synthetic biology-based strategy: a review

Secretory Production of Tocotrienols in Saccharomyces Cerevisiae

Statistical studies of heart disease. IX. Race and sex differences in the trend of mortality from the major cardiovascular-renal diseases.

Enhancing Gastrodin Production in Yarrowia lipolytica by Metabolic Engineering

Production of plant natural products through engineered <i>Yarrowia lipolytica</i>

Remodelling metabolism for high-level resveratrol production in Yarrowia lipolytica

[Quality assurance of antibiotic therapy at the Hvidovre Hospital. Results of an audit project].

Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae

The Synthesis of Ginsenoside Compound K Using a Surface-Displayed β-Glycosidase Whole-Cell Catalyst

Mosaic variegated aneuploidy with growth hormone deficiency and congenital heart defects.

Efficient synthesis of squalene by cytoplasmic-peroxisomal engineering and regulating lipid metabolism in Yarrowia lipolytica

High titer production of gastrodin enabled by systematic refactoring of yeast genome and an antisense-transcriptional regulation toolkit

Optimizing Oleaginous Yeast Cell Factories for Flavonoids and Hydroxylated Flavonoids Biosynthesis

Synthesizing ginsenoside Rh2 in Saccharomyces cerevisiae cell factory at high-efficiency